Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Precision Biosciences (DTIL) Other Non-Current Liabilities (2020 - 2025)

Precision Biosciences (DTIL) has disclosed Other Non-Current Liabilities for 6 consecutive years, with $10.0 million as the latest value for Q4 2025.

  • Quarterly Other Non-Current Liabilities changed 0.0% to $10.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $10.0 million through Dec 2025, changed 0.0% year-over-year, with the annual reading at $10.0 million for FY2025, 0.0% changed from the prior year.
  • Other Non-Current Liabilities for Q4 2025 was $10.0 million at Precision Biosciences, up from $4.0 million in the prior quarter.
  • The five-year high for Other Non-Current Liabilities was $22.0 million in Q1 2024, with the low at $34000.0 in Q1 2022.
  • Average Other Non-Current Liabilities over 5 years is $8.5 million, with a median of $10.0 million recorded in 2021.
  • The sharpest move saw Other Non-Current Liabilities crashed 97.99% in 2022, then soared 29311.76% in 2023.
  • Over 5 years, Other Non-Current Liabilities stood at $10.0 million in 2021, then plummeted by 97.99% to $201000.0 in 2022, then soared by 4875.12% to $10.0 million in 2023, then changed by 0.0% to $10.0 million in 2024, then changed by 0.0% to $10.0 million in 2025.
  • According to Business Quant data, Other Non-Current Liabilities over the past three periods came in at $10.0 million, $4.0 million, and $2.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.